Skull injection for severe stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether injecting a special solution (RK-4) into the skull can help people with a severe type of stroke caused by a blockage in a major brain artery. The treatment aims to reduce brain damage and improve recovery when given within 24 hours of the stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have had a stroke in the middle cerebral artery area, which is a main blood vessel in the brain.
- Your stroke symptoms must be moderate to severe.
- The study treatment must be given within 24 hours of the stroke starting.
- Before the stroke, you must have been independent (score 0 or 1 on the modified Rankin scale).
- If you had standard clot-removal treatment, it must not have worked well.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver a medication called RK-4 directly into the skull bone marrow to bypass the blood-brain barrier for people with a major stroke on one side of the brain. The goal is to see if this injection is safe and feasible, and it might help reduce damage after a severe stroke.
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
This trial tests an experimental treatment called RK-4 that is given directly into the bone of the skull shortly after a severe stroke. The goal is to see if it can improve recovery and reduce disability from a major stroke on one side of the brain.
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
This study tests a clot-busting medicine given through an IV to people who had a stroke caused by a blocked medium-sized blood vessel in the brain, and who can be treated 4.5 to 24 hours after symptoms start. The goal is to see if it improves recovery and reduces disability compared to standard care.
This trial tests an investigational drug, QHRD106, given as an injection for people who have had a moderate-to-severe acute ischemic stroke. It aims to see if the drug can help recovery when given within 24 hours after the stroke starts, and it is for patients who are not receiving standard clot-busting treatment.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.